US EPA

6869556 

Journal Article 

A novel human 3D lung microtissue model for nanoparticle-induced cell-matrix alterations 

Kabadi, PK; Rodd, AL; Simmons, AE; Messier, NJ; Hurt, RH; Kane, AB 

2019 

1 

Particle and Fibre Toxicology
EISSN: 1743-8977 

BMC 

LONDON 

16 

1 

15 

English 

30943996 

10.1186/s12989-019-0298-0 

WOS:000463602300001 

https://www.scopus.com/inward/record.uri?eid=2-s2.0-85063951235&doi=10.1186%2fs12989-019-0298-0&partnerID=40&md5=dadf75dc92a4395f84ab81198ef6043a
Exit
 

BACKGROUND: Multi-walled carbon nanotubes (MWCNT) have been shown to elicit the release of inflammatory and pro-fibrotic mediators, as well as histopathological changes in lungs of exposed animals. Current standards for testing MWCNTs and other nanoparticles (NPs) rely on low-throughput in vivo studies to assess acute and chronic toxicity and potential hazard to humans. Several alternative testing approaches utilizing two-dimensional (2D) in vitro assays to screen engineered NPs have reported conflicting results between in vitro and in vivo assays. Compared to conventional 2D in vitro or in vivo animal model systems, three-dimensional (3D) in vitro platforms have been shown to more closely recapitulate human physiology, providing a relevant, more efficient strategy for evaluating acute toxicity and chronic outcomes in a tiered nanomaterial toxicity testing paradigm.

RESULTS: As inhalation is an important route of nanomaterial exposure, human lung fibroblasts and epithelial cells were co-cultured with macrophages to form scaffold-free 3D lung microtissues. Microtissues were exposed to multi-walled carbon nanotubes, M120 carbon black nanoparticles or crocidolite asbestos fibers for 4 or 7 days, then collected for characterization of microtissue viability, tissue morphology, and expression of genes and selected proteins associated with inflammation and extracellular matrix remodeling. Our data demonstrate the utility of 3D microtissues in predicting chronic pulmonary endpoints following exposure to MWCNTs or asbestos fibers. These test nanomaterials were incorporated into 3D human lung microtissues as visualized using light microscopy. Differential expression of genes involved in acute inflammation and extracellular matrix remodeling was detected using PCR arrays and confirmed using qRT-PCR analysis and Luminex assays of selected genes and proteins.

CONCLUSION: 3D lung microtissues provide an alternative testing platform for assessing nanomaterial-induced cell-matrix alterations and delineation of toxicity pathways, moving towards a more predictive and physiologically relevant approach for in vitro NP toxicity testing. 

Cell-matrix interactions; Human lung microtissues; In vitro testing methods; Multi-walled carbon nanotubes; Nanoparticles; Three-dimensional spheroids